Projections and Epidemiology of Revision Hip and Knee Arthroplasty in the United States to 2030

  • Andrew M. Schwartz
    Correspondence
    Reprint requests: Andrew M. Schwartz, MD, Department of Orthopaedic Surgery, Emory University School of Medicine, 59 Executive Park Drive, SE, Atlanta, GA 30329.
    Affiliations
    Department of Orthopaedic Surgery, Emory University School of Medicine, Atlanta, GA

    Department of Orthopaedic Surgery, Emory University Orthopaedics & Spine Hospital, Tucker, GA
    Search for articles by this author
  • Kevin X. Farley
    Affiliations
    Department of Orthopaedic Surgery, Emory University School of Medicine, Atlanta, GA
    Search for articles by this author
  • George N. Guild
    Affiliations
    Department of Orthopaedic Surgery, Emory University School of Medicine, Atlanta, GA

    Department of Orthopaedic Surgery, Emory University Orthopaedics & Spine Hospital, Tucker, GA
    Search for articles by this author
  • Thomas L. Bradbury Jr.
    Affiliations
    Department of Orthopaedic Surgery, Emory University School of Medicine, Atlanta, GA

    Department of Orthopaedic Surgery, Emory University Orthopaedics & Spine Hospital, Tucker, GA
    Search for articles by this author
Published:February 19, 2020DOI:https://doi.org/10.1016/j.arth.2020.02.030

      Abstract

      Background

      As the incidence of primary total joint arthroplasty rises in the United States, it is important to investigate how this will impact rates of revision arthroplasty. The purpose of this study was to analyze the incidence and future projections of revision total hip arthroplasty (rTHA) and revision total knee arthroplasty (rTKA) to 2030. Anticipating surgical volume will aid surgeons in designing protocols to efficiently and effectively perform rTHA/rTKA.

      Methods

      The national inpatient sample was queried from 2002 to 2014 for all rTHA/rTKA. Using previously validated measures, Poisson and linear regression analyses were performed to project annual incidence of rTHA/rTKA to 2030, with subgroup analyses on modes of failure and age.

      Results

      In 2014, there were 50,220 rTHAs and 72,100 rTKAs. From 2014 to 2030, rTHA incidence is projected to increase by between 43% and 70%, whereas rTKA incidence is projected to increase by between 78% and 182%. The 55-64 and 65-74 age groups increased in revision incidence during the study period, whereas 75-84 age group decreased in incidence. For rTKA, infection and aseptic loosening are the 2 most common modes of failure, whereas periprosthetic fracture and infection are most common for rTHA.

      Conclusion

      The incidence of rTHA/rTKA is projected to increase, particularly in young patients and for infection. Given the known risk factor profiles and advanced costs associated with revision arthroplasty, our projections should encourage institutions to generate revision-specific protocols to promote safe pathways for cost-effective care that is commensurate with current value-based health care trends.

      Level of Evidence

      IV.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal of Arthroplasty
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Fingar K.R.
        • Stocks C.
        • Weiss A.J.
        • Steiner C.A.
        Most Frequent Operating Room Procedures Performed in U.S. Hospitals, 2003-2012: Statistical Brief #186, in Healthcare Cost and Utilization Project (HCUP) Statistical Briefs.
        Agency for Healthcare Research and Quality (US), Rockville, MD2006
        • Palsis J.A.
        • Brehmer T.S.
        • Pellegrini V.D.
        • Drew J.M.
        • Sachs B.L.
        The cost of joint replacement: comparing two approaches to evaluating costs of total hip and knee arthroplasty.
        J Bone Joint Surg Am. 2018; 100: 326-333
        • Gabriel L.
        • Casey J.
        • Gee M.
        • Palmer C.
        • Sinha J.
        • Moxham J.
        • et al.
        Value-based healthcare analysis of joint replacement surgery for patients with primary hip osteoarthritis.
        BMJ Open Qual. 2019; 8: e000549
        • Castagnini F.
        • Sudanese A.
        • Bordini B.
        • Tassinari E.
        • Stea S.
        • Toni A.
        Total knee replacement in young patients: survival and causes of revision in a registry population.
        J Arthroplasty. 2017; 32: 3368-3372
        • Gademan M.G.
        • Hofstede S.N.
        • Vliet Vlieland T.P.
        • Nelissen R.G.
        • Marang-van de Mheen P.J.
        Indication criteria for total hip or knee arthroplasty in osteoarthritis: a state-of-the-science overview.
        BMC Musculoskelet Disord. 2016; 17: 463
        • McLawhorn A.S.
        • Buller L.T.
        Bundled payments in total joint replacement: keeping our care affordable and high in quality.
        Curr Rev Musculoskelet Med. 2017; 10: 370-377
        • Luna I.E.
        • Kehlet H.
        • Peterson B.
        • Wede H.R.
        • Hoevsgaard S.J.
        • Aasvang E.K.
        Early patient-reported outcomes versus objective function after total hip and knee arthroplasty: a prospective cohort study.
        Bone Joint J. 2017; 99-B: 1167-1175
        • Springer B.D.
        • Odum S.M.
        • Vegari D.N.
        • Mokris J.G.
        • Beaver Jr., W.B.
        Impact of inpatient versus outpatient total joint arthroplasty on 30-day hospital readmission rates and unplanned episodes of care.
        Orthop Clin North Am. 2017; 48: 15-23
        • Amanatullah D.F.
        • McQuillan T.
        • Kamal R.N.
        Quality measures in total hip and total knee arthroplasty.
        J Am Acad Orthop Surg. 2019; 27: 219-226
        • Kamaruzaman H.
        • Kinghorn P.
        • Oppong R.
        Cost-effectiveness of surgical interventions for the management of osteoarthritis: a systematic review of the literature.
        BMC Musculoskelet Disord. 2017; 18: 183
        • Schwartz A.J.
        • Bozic K.J.
        • Etzioni D.A.
        Value-based total hip and knee arthroplasty: a framework for understanding the literature.
        J Am Acad Orthop Surg. 2019; 27: 1-11
        • Quintana J.M.
        • Arostegui I.
        • Escobar A.
        • Azkarate J.
        • Goenaga J.I.
        • Lafuente I.
        Prevalence of knee and hip osteoarthritis and the appropriateness of joint replacement in an older population.
        Arch Intern Med. 2008; 168: 1576-1584
        • Sobieraj M.
        • Marwin S.
        Ultra-high-molecular-weight polyethylene (UHMWPE) in total joint arthroplasty.
        Bull Hosp Jt Dis (2013). 2018; 76: 38-46
        • Lim S.J.
        • Jang S.P.
        • Kim D.W.
        • Moon Y.W.
        • Park Y.S.
        Primary ceramic-on-ceramic total hip arthroplasty using a 32-mm ceramic head with a titanium-alloy sleeve.
        Clin Orthop Relat Res. 2015; 473: 3781-3787
        • Delaunay C.P.
        • Putman S.
        • Puliero B.
        • Begin M.
        • Migaud H.
        • Bonnomet F.
        Cementless total hip arthroplasty with metasul bearings provides good results in active young patients: a concise followup.
        Clin Orthop Relat Res. 2016; 474: 2126-2133
        • Bayliss L.E.
        • Culliford D.
        • Monk A.P.
        • Glyn-Jones S.
        • Prieto-Alhambra D.
        • Judge A.
        • et al.
        The effect of patient age at intervention on risk of implant revision after total replacement of the hip or knee: a population-based cohort study.
        Lancet. 2017; 389: 1424-1430
        • Ravi B.
        • Croxford R.
        • Reichmann W.M.
        • Losina E.
        • Katz J.N.
        • Hawker G.A.
        The changing demographics of total joint arthroplasty recipients in the United States and Ontario from 2001 to 2007.
        Best Pract Res Clin Rheumatol. 2012; 26: 637-647
        • Sedrakyan A.
        • Romero L.
        • Graves S.
        • Davidson D.
        • de Steiger R.
        • Lewis P.
        • et al.
        Survivorship of hip and knee implants in pediatric and young adult populations: analysis of registry and published data.
        J Bone Joint Surg Am. 2014; 96: 73-78
        • Martin J.R.
        • Sutak A.K.
        • Milbrandt T.A.
        • Martin V.A.
        • Trousdale R.T.
        Adolescent total knee arthroplasty.
        Arthroplast Today. 2017; 3: 105-109
        • Hannouche D.
        • Devriese F.
        • Delambre J.
        • Zadegan F.
        • Tourabaly I.
        • Sedel L.
        • et al.
        Ceramic-on-ceramic THA implants in patients younger than 20 years.
        Clin Orthop Relat Res. 2016; 474: 520-527
        • Bohl D.D.
        • Samuel A.M.
        • Basques B.A.
        • Della Valle C.J.
        • Levine B.R.
        • Grauer J.N.
        How much do adverse event rates differ between primary and revision total joint arthroplasty?.
        J Arthroplasty. 2016; 31: 596-602
        • Isaacson M.J.
        • Bunn K.J.
        • Noble P.C.
        • Ismaily S.K.
        • Incavo S.J.
        Quantifying and predicting surgeon work input in primary vs revision total hip arthroplasty.
        J Arthroplasty. 2016; 31: 1188-1193
        • Bunn K.J.
        • Isaacson M.J.
        • Ismaily S.K.
        • Noble P.C.
        • Incavo S.J.
        Quantifying and predicting surgeon work effort for primary and revision total knee arthroplasty.
        J Arthroplasty. 2016; 31: 59-62
        • Nichols C.I.
        • Vose J.G.
        Clinical outcomes and costs within 90 days of primary or revision total joint arthroplasty.
        J Arthroplasty. 2016; 31: 1400-1406.e3
        • Tessier J.E.
        • Rupp G.
        • Gera J.T.
        • DeHart M.L.
        • Kowalik T.D.
        • Duwelius P.J.
        Physicians with defined clear care pathways have better discharge disposition and lower cost.
        J Arthroplasty. 2016; 31: 54-58
        • Sloan M.
        • Premkumar A.
        • Sheth N.P.
        Projected volume of primary total joint arthroplasty in the U.S., 2014 to 2030.
        J Bone Joint Surg Am. 2018; 100: 1455-1460
        • Kurtz S.
        • Ong K.
        • Lau E.
        • Mowat F.
        • Halpern M.
        Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030.
        J Bone Joint Surg Am. 2007; 89: 780-785
        • Kurtz S.M.
        • Lau E.C.
        • Son M.S.
        • Chang E.T.
        • Zimmerli W.
        • Parvizi J.
        Are we winning or losing the battle with periprosthetic joint infection: trends in periprosthetic joint infection and mortality risk for the medicare population.
        J Arthroplasty. 2018; 33: 3238-3245
        • Henderson R.A.
        • Austin M.S.
        Management of periprosthetic joint infection: the more we learn, the less we know.
        J Arthroplasty. 2017; 32: 2056-2059
        • Kokko M.A.
        • Abdel M.P.
        • Berry D.J.
        • Butler R.D.
        • Van Citters D.W.
        A retrieval analysis perspective on revision for infection.
        Arthroplast Today. 2019; 5: 362-370
        • Haidukewych G.J.
        • Langford J.
        • Liporace F.A.
        Revision for periprosthetic fractures of the hip and knee.
        J Bone Joint Surg Am. 2013; 95: 368-376
        • Frank R.M.
        • Cross M.B.
        • Della Valle C.J.
        Periprosthetic joint infection: modern aspects of prevention, diagnosis, and treatment.
        J Knee Surg. 2015; 28: 105-112
        • Kapadia B.H.
        • Pivec R.
        • Johnson A.J.
        • Issa K.
        • Naziri Q.
        • Daley J.A.
        • et al.
        Infection prevention methodologies for lower extremity total joint arthroplasty.
        Expert Rev Med Devices. 2013; 10: 215-224
        • Zalavras C.G.
        • Springer B.D.
        Editorial comment: 2016 Musculoskeletal Infection Society Proceedings.
        Clin Orthop Relat Res. 2017; 475: 1796-1797
        • Koh C.K.
        • Zeng I.
        • Ravi S.
        • Zhu M.
        • Vince K.G.
        • Young S.W.
        Periprosthetic joint infection is the main cause of failure for modern knee arthroplasty: an analysis of 11,134 knees.
        Clin Orthop Relat Res. 2017; 475: 2194-2201
        • Tarabichi M.
        • Shohat N.
        • Goswami K.
        • Alvand A.
        • Silibovsky R.
        • Belden K.
        • et al.
        Diagnosis of periprosthetic joint infection: the potential of next-generation sequencing.
        J Bone Joint Surg Am. 2018; 100: 147-154
        • Jacovides C.L.
        • Kreft R.
        • Adeli B.
        • Hozack B.
        • Ehrlich G.D.
        • Parvizi J.
        Successful identification of pathogens by polymerase chain reaction (PCR)-based electron spray ionization time-of-flight mass spectrometry (ESI-TOF-MS) in culture-negative periprosthetic joint infection.
        J Bone Joint Surg Am. 2012; 94: 2247-2254
        • Parvizi J.
        • Tan T.L.
        • Goswami K.
        • Higuera C.
        • Della Valle C.
        • Chen A.F.
        • et al.
        The 2018 definition of periprosthetic hip and knee infection: an evidence-based and validated criteria.
        J Arthroplasty. 2018; 33: 1309-1314.e2
        • Koh I.J.
        • Han S.B.
        • In Y.
        • Oh K.J.
        • Lee D.H.
        • Kim T.K.
        The leukocyte esterase strip test has practical value for diagnosing periprosthetic joint infection after total knee arthroplasty: a multicenter study.
        J Arthroplasty. 2017; 32: 3519-3523
        • Wyatt M.C.
        • Beswick A.D.
        • Kunutsor S.K.
        • Wilson M.J.
        • Whitehouse M.R.
        • Blom A.W.
        The alpha-defensin immunoassay and leukocyte esterase colorimetric strip test for the diagnosis of periprosthetic infection: a systematic review and meta-analysis.
        J Bone Joint Surg Am. 2016; 98: 992-1000
        • Shahi A.
        • Kheir M.M.
        • Tarabichi M.
        • Hosseinzadeh H.R.S.
        • Tan T.L.
        • Parvizi J.
        Serum D-Dimer test is promising for the diagnosis of periprosthetic joint infection and timing of reimplantation.
        J Bone Joint Surg Am. 2017; 99: 1419-1427
        • Ottesen C.S.
        • Troelsen A.
        • Sandholdt H.
        • Jacobsen S.
        • Husted H.
        • Gromov K.
        Acceptable success rate in patients with periprosthetic knee joint infection treated with debridement, antibiotics, and implant retention.
        J Arthroplasty. 2019; 34: 365-368
        • Puhto T.
        • Puhto A.P.
        • Vielma M.
        • Syrjala H.
        Infection triples the cost of a primary joint arthroplasty.
        Infect Dis (Lond). 2019; 51: 348-355
        • Kasch R.
        • Assmann G.
        • Merk S.
        • Barz T.
        • Melloh M.
        • Hofer A.
        • et al.
        Economic analysis of two-stage septic revision after total hip arthroplasty: what are the relevant costs for the hospital's orthopedic department?.
        BMC Musculoskelet Disord. 2016; 17: 112
        • Boddapati V.
        • Fu M.C.
        • Mayman D.J.
        • Su E.P.
        • Sculco P.K.
        • McLawhorn A.S.
        Revision total knee arthroplasty for periprosthetic joint infection is associated with increased postoperative morbidity and mortality relative to noninfectious revisions.
        J Arthroplasty. 2018; 33: 521-526
        • Boddapati V.
        • Fu M.C.
        • Tetreault M.W.
        • Blevins J.L.
        • Richardson S.S.
        • Su E.P.
        Short-term complications after revision hip arthroplasty for prosthetic joint infection are increased relative to noninfectious revisions.
        J Arthroplasty. 2018; 33: 2997-3002
        • Fischbacher A.
        • Borens O.
        Prosthetic-joint infections: mortality over the last 10 years.
        J Bone Jt Infect. 2019; 4: 198-202
        • Reeves R.A.
        • Schairer W.W.
        • Jevsevar D.S.
        Costs and risk factors for hospital readmission after periprosthetic knee fractures in the United States.
        J Arthroplasty. 2018; 33: 324-330.e1
        • Reeves R.A.
        • Schairer W.W.
        • Jevsevar D.S.
        The national burden of periprosthetic hip fractures in the US: costs and risk factors for hospital readmission.
        Hip Int. 2019; 29: 550-557
        • Kurtz S.M.
        • Lau E.C.
        • Ong K.L.
        • Adler E.M.
        • Kolisek F.R.
        • Manley M.T.
        Which clinical and patient factors influence the national economic burden of hospital readmissions after total joint arthroplasty?.
        Clin Orthop Relat Res. 2017; 475: 2926-2937
        • Khan M.
        • Osman K.
        • Green G.
        • Haddad F.S.
        The epidemiology of failure in total knee arthroplasty: avoiding your next revision.
        Bone Joint J. 2016; 98-B: 105-112
        • Riesgo A.M.
        • Hochfelder J.P.
        • Adler E.M.
        • Slover J.D.
        • Specht L.M.
        • Iorio R.
        Survivorship and complications of revision total hip arthroplasty with a mid-modular femoral stem.
        J Arthroplasty. 2015; 30: 2260-2263
        • Vessely M.B.
        • Whaley A.L.
        • Harmsen W.S.
        • Schleck C.D.
        • Berry D.J.
        The Chitranjan Ranawat Award: long-term survivorship and failure modes of 1000 cemented condylar total knee arthroplasties.
        Clin Orthop Relat Res. 2006; 452: 28-34
        • Evans J.T.
        • Walker R.W.
        • Evans J.P.
        • Blom A.W.
        • Sayers A.
        • Whitehouse M.R.
        How long does a knee replacement last? A systematic review and meta-analysis of case series and national registry reports with more than 15 years of follow-up.
        Lancet. 2019; 393: 655-663
        • Evans J.T.
        • Evans J.P.
        • Walker R.W.
        • Blom A.W.
        • Whitehouse M.R.
        • Sayers A.
        How long does a hip replacement last? A systematic review and meta-analysis of case series and national registry reports with more than 15 years of follow-up.
        Lancet. 2019; 393: 647-654
        • McGloughlin T.M.
        • Kavanagh A.G.
        Wear of ultra-high molecular weight polyethylene (UHMWPE) in total knee prostheses: a review of key influences.
        Proc Inst Mech Eng H. 2000; 214: 349-359
        • Digas G.
        • Karrholm J.
        • Thanner J.
        • Malchau H.
        • Herberts P.
        The Otto Aufranc Award. Highly cross-linked polyethylene in total hip arthroplasty: randomized evaluation of penetration rate in cemented and uncemented sockets using radiostereometric analysis.
        Clin Orthop Relat Res. 2004; 429: 6-16
        • Mannan K.
        • Scott G.
        The Medial Rotation total knee replacement: a clinical and radiological review at a mean follow-up of six years.
        J Bone Joint Surg Br. 2009; 91: 750-756
        • Darrith B.
        • Courtney P.M.
        • Della Valle C.J.
        Outcomes of dual mobility components in total hip arthroplasty: a systematic review of the literature.
        Bone Joint J. 2018; 100-B: 11-19
        • Shareghi B.
        • Johanson P.E.
        • Karrholm J.
        Wear of vitamin E-infused highly cross-linked polyethylene at five years.
        J Bone Joint Surg Am. 2017; 99: 1447-1452
        • Lee G.C.
        • Kim R.H.
        Incidence of modern alumina ceramic and alumina matrix composite femoral head failures in nearly 6 million hip implants.
        J Arthroplasty. 2017; 32: 546-551
        • Lim S.J.
        • Kim S.M.
        • Kim D.W.
        • Moon Y.W.
        • Park Y.S.
        Cementless total hip arthroplasty using Biolox(R)delta ceramic-on-ceramic bearing in patients with osteonecrosis of the femoral head.
        Hip Int. 2016; 26: 144-148
        • Lim S.J.
        • Ryu H.G.
        • Eun H.J.
        • Park C.W.
        • Kwon K.B.
        • Park Y.S.
        Clinical outcomes and bearing-specific complications following fourth-generation alumina ceramic-on-ceramic total hip arthroplasty: a single-surgeon series of 749 hips at a minimum of 5-year follow-up.
        J Arthroplasty. 2018; 33: 2182-2186.e1
        • Kumar A.
        • Bloch B.V.
        • Esler C.
        Trends in total hip arthroplasty in young patients—results from a regional register.
        Hip Int. 2017; 27: 443-448
        • Aujla R.S.
        • Esler C.N.
        Total knee arthroplasty for osteoarthritis in patients less than fifty-five years of age: a systematic review.
        J Arthroplasty. 2017; 32: 2598-2603.e1
        • Charette R.S.
        • Sloan M.
        • DeAngelis R.D.
        • Lee G.-C.
        Higher rate of early revision following primary total knee arthroplasty in patients under age 55: a cautionary tale.
        J Arthroplasty. 2019; 34: 2918-2924
        • Postler A.E.
        • Beyer F.
        • Wegner T.
        • Lutzner J.
        • Hartmann A.
        • Ojodu I.
        • et al.
        Patient-reported outcomes after revision surgery compared to primary total hip arthroplasty.
        Hip Int. 2017; 27: 180-186
        • Scott C.E.H.
        • Turnbull G.S.
        • Powell-Bowns M.F.R.
        • MacDonald D.J.
        • Breusch S.J.
        Activity levels and return to work after revision total hip and knee arthroplasty in patients under 65 years of age.
        Bone Joint J. 2018; 100-B: 1043-1053
        • Watts C.D.
        • Abdel M.P.
        • Lewallen D.G.
        • Berry D.J.
        • Hanssen A.D.
        Increased risk of periprosthetic femur fractures associated with a unique cementless stem design.
        Clin Orthop Relat Res. 2015; 473: 2045-2053
        • Wang D.
        • Li L.L.
        • Wang H.Y.
        • Pei F.X.
        • Zhou Z.K.
        Long-term results of cementless total hip arthroplasty with subtrochanteric shortening osteotomy in crowe type IV developmental dysplasia.
        J Arthroplasty. 2017; 32: 1211-1219
        • Tan T.L.
        • Kheir M.M.
        • Tan D.D.
        • Filippone E.J.
        • Tischler E.H.
        • Chen A.F.
        Chronic kidney disease linearly predicts outcomes after elective total joint arthroplasty.
        J Arthroplasty. 2016; 31: 175-179.e2
        • Maradit Kremers H.
        • Lewallen L.W.
        • Mabry T.M.
        • Berry D.J.
        • Berbari E.F.
        • Osmon D.R.
        Diabetes mellitus, hyperglycemia, hemoglobin A1C and the risk of prosthetic joint infections in total hip and knee arthroplasty.
        J Arthroplasty. 2015; 30: 439-443
        • Chrastil J.
        • Anderson M.B.
        • Stevens V.
        • Anand R.
        • Peters C.L.
        • Pelt C.E.
        Is hemoglobin A1c or perioperative hyperglycemia predictive of periprosthetic joint infection or death following primary total joint arthroplasty?.
        J Arthroplasty. 2015; 30: 1197-1202
        • Courtney P.M.
        • Huddleston J.I.
        • Iorio R.
        • Markel D.C.
        Socioeconomic risk adjustment models for reimbursement are necessary in primary total joint arthroplasty.
        J Arthroplasty. 2017; 32: 1-5
        • Oh C.
        • Slover J.D.
        • Bosco J.A.
        • Iorio R.
        • Gold H.T.
        Time trends in characteristics of patients undergoing primary total hip and knee arthroplasty in California, 2007-2010.
        J Arthroplasty. 2018; 33: 2376-2380
        • Kirksey M.
        • Chiu Y.L.
        • Ma Y.
        • Della Valle A.G.
        • Poultsides L.
        • Gerner P.
        • et al.
        Trends in in-hospital major morbidity and mortality after total joint arthroplasty: United States 1998-2008.
        Anesth Analg. 2012; 115: 321-327
        • Grosso M.J.
        • Neuwirth A.L.
        • Boddapati V.
        • Shah R.P.
        • Cooper H.J.
        • Geller J.A.
        Decreasing length of hospital stay and postoperative complications after primary total hip arthroplasty: a decade analysis from 2006 to 2016.
        J Arthroplasty. 2019; 34: 422-425
        • Molloy I.B.
        • Martin B.I.
        • Moschetti W.E.
        • Jevsevar D.S.
        Effects of the length of stay on the cost of total knee and total hip arthroplasty from 2002 to 2013.
        J Bone Joint Surg Am. 2017; 99: 402-407
        • Burn E.
        • Edwards C.J.
        • Murray D.W.
        • Silman A.
        • Cooper C.
        • Arden N.K.
        • et al.
        Trends and determinants of length of stay and hospital reimbursement following knee and hip replacement: evidence from linked primary care and NHS hospital records from 1997 to 2014.
        BMJ Open. 2018; 8: e019146
        • Maradit Kremers H.
        • Larson D.R.
        • Crowson C.S.
        • Kremers W.K.
        • Washington R.E.
        • Steiner C.A.
        • et al.
        Prevalence of total hip and knee replacement in the United States.
        J Bone Joint Surg Am. 2015; 97: 1386-1397
        • Singh J.A.
        • Yu S.
        • Chen L.
        • Cleveland J.D.
        Rates of total joint replacement in the United States: future projections to 2020-2040 using the national inpatient sample.
        J Rheumatol. 2019; 9: 1134-1140
        • Inacio M.C.S.
        • Paxton E.W.
        • Graves S.E.
        • Namba R.S.
        • Nemes S.
        Projected increase in total knee arthroplasty in the United States—an alternative projection model.
        Osteoarthritis Cartilage. 2017; 25: 1797-1803
        • Inacio M.C.S.
        • Graves S.E.
        • Pratt N.L.
        • Roughead E.E.
        • Nemes S.
        Increase in total joint arthroplasty projected from 2014 to 2046 in Australia: a conservative local model with international implicat ions.
        Clin Orthop Relat Res. 2017; 475: 2130-2137
        • Rutherford R.W.
        • Jennings J.M.
        • Dennis D.A.
        Enhancing recovery after total knee arthroplasty.
        Orthop Clin North Am. 2017; 48: 391-400
        • McCann-Spry L.
        • Pelton J.
        • Grandy G.
        • Newell D.
        An interdisciplinary approach to reducing length of stay in joint replacement patients.
        Orthop Nurs. 2016; 35: 279-298
        • Bullock M.W.
        • Brown M.L.
        • Bracey D.N.
        • Langfitt M.K.
        • Shields J.S.
        • Lang J.E.
        A bundle protocol to reduce the incidence of periprosthetic joint infections after total joint arthroplasty: a single-center experience.
        J Arthroplasty. 2017; 32: 1067-1073
        • Golladay G.J.
        • Balch K.R.
        • Dalury D.F.
        • Satpathy J.
        • Jiranek W.A.
        Oral multimodal analgesia for total joint arthroplasty.
        J Arthroplasty. 2017; 32: S69-S73
        • Dattilo J.
        • Gittings D.
        • Sloan M.
        • Charette R.
        • Hume E.
        • Lee G.C.
        ‘Hot Joints’ infection protocol reduces unnecessary post-operative re-admissions following total hip and knee arthroplasty.
        Bone Joint J. 2017; 99-B: 1603-1610
        • Marinier M.
        • Edmiston T.A.
        • Kearns S.
        • Hannon C.P.
        • Levine B.R.
        A survey of the prevalence of and techniques to prevent trunnionosis.
        Orthopedics. 2018; 41: e557-e562
        • Cooper H.J.
        • Della Valle C.J.
        • Berger R.A.
        • Tetreault M.
        • Paprosky W.G.
        • Sporer S.M.
        • et al.
        Corrosion at the head-neck taper as a cause for adverse local tissue reactions after total hip arthroplasty.
        J Bone Joint Surg Am. 2012; 94: 1655-1661
        • Cooper H.J.
        • Urban R.M.
        • Wixson R.L.
        • Meneghini R.M.
        • Jacobs J.J.
        Adverse local tissue reaction arising from corrosion at the femoral neck-body junction in a dual-taper stem with a cobalt-chromium modular neck.
        J Bone Joint Surg Am. 2013; 95: 865-872
        • Bernstein D.T.
        • Meftah M.
        • Paranilam J.
        • Incavo S.J.
        Eighty-six percent failure rate of a modular-neck femoral stem design at 3 to 5 Years: lessons learned.
        J Bone Joint Surg Am. 2016; 98: e49
        • Waterson H.B.
        • Whitehouse M.R.
        • Greidanus N.V.
        • Garbuz D.S.
        • Masri B.A.
        • Duncan C.P.
        Revision for adverse local tissue reaction following metal-on-polyethylene total hip arthroplasty is associated with a high risk of early major complications.
        Bone Joint J. 2018; 100-B: 720-724
        • Dimitriou D.
        • Liow M.H.
        • Tsai T.Y.
        • Leone W.A.
        • Li G.
        • Kwon Y.M.
        Early outcomes of revision surgery for taper corrosion of dual taper total hip arthroplasty in 187 patients.
        J Arthroplasty. 2016; 31: 1549-1554